Sensitizer related hypersensitivity pneumonitis is a dubious disease in the area of infectious respiratory digestive and endocrine disorders. Clinical performance is complex and often involves multi-system congestion. Early identification and standardization of clinical treatments are essential for improving prognosis.
The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation. The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of Sensitizer related hypersensitivity pneumonitis requires individualized treatment, typically including drug therapy, rehabilitation interventions, regular follow-up, and multi-dimensional management.
In recent years, with the development of treatment-oriented, immune-regulating treatments and precision medicine, many previously difficult-to-treat infectious respiratory digestive and endocrine diseases have been significantly improved. Multi-disciplinary collaboration (MDT) is particularly important for the comprehensive management of Sensitizer related hypersensitivity pneumonitis. Platform services China International Medical Service System combines domestic and foreign authoritative experts in the field of infectious respiratory digestion and endocrinology to provide the following services to patients: 3.
Full service: providing one-stop services, such as medical translation, medical accompaniment, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.